Clinical Study

Signals from the frontier

Observations from the edge of BCI science and the industry.

Recent Blogs

  • Date (Newest)
  • Date (Oldest)
  • Title (A-Z)
  • Title (Z-A)
  • Most Popular
  • All
  • AI
  • Company Updates
  • Neurotech
  • Regulatory
  • Scientific Deep Dives

Brain-Computer Interfaces

China's Recent Developments and What They Mean for the U.S.

China's first commercially approved BCI made headlines. Here's what U.S. investors and policymakers need to know about the real state of the BCI race.

Closing the Loop on Mental Health

How High-Bandwidth Brain-Computer Interfaces Could Transform Psychiatric Treatment

Emerging high-resolution brain-computer interfaces combined with AI-driven decoding methods may finally make it possible to objectively track and regulate mood states in real time, shifting psychiatry from trial-and-error treatment toward personalized, closed-loop care.

Defining Success in Clinical-Stage BCIs

What Truly Matters for BCI Users

Clinical-stage BCIs should be evaluated by how well they restore user independence, support digital daily living, and enable natural communication.

Paradromics at SfN 2025

Signal to Noise Ratio

Paradromics shares preclinical results showing stable neural signal quality over a year with the Connexus BCI.

Measuring What Matters in BCI

A Genuine Commitment to Users Requires Rigorous Accountability

For meaningful progress, BCI outcome measures need to show both functional independence and quality of performance.

Healthtech and the FDA

Fueling Collaborative Regulation in Neurotechnology

The FDA continues to work with healthtech innovators to meet the expanding size of the BCI market.

BCI Tech

Brain Implants and the Future of Healthcare

BCI tech is revolutionizing healthcare, with brain implants poised to transform neurological and mental health treatment.